Batra S, Srinivasan T, Rastogi S K, Kundu B
Medicinal Chemistry Division, Central Drug Research Institute, Lucknow-226001, Lucknow, India.
Curr Med Chem. 2002 Feb;9(3):307-19. doi: 10.2174/0929867023371120.
Potent enzyme inhibitors have long been recognized as powerful tools for assessing the physiological roles of enzymes and have led to the therapeutic drugs able to modulate their activities in vivo. However, to be valuable tools such inhibitors should be selective so that they do not interfere with other members of the particular enzyme family. Combinatorial chemistry has proven to be a novel approach for the identification of molecules with a desired selectivity profile from the libraries of several million compounds. In recent years it has been extensively used in conjunction with computational methods for the development of potent inhibitors of therapeutically interesting targets. This review describes the various structurally diverse enzyme inhibitors identified by screening combinatorial libraries of peptides and small organic molecules.
强效酶抑制剂长期以来一直被视为评估酶生理作用的有力工具,并催生了能够在体内调节其活性的治疗药物。然而,要成为有价值的工具,此类抑制剂应具有选择性,以免干扰特定酶家族的其他成员。组合化学已被证明是一种从数百万种化合物库中鉴定具有所需选择性特征分子的新方法。近年来,它已广泛与计算方法结合使用,以开发针对具有治疗意义靶点的强效抑制剂。本综述描述了通过筛选肽和小分子组合文库鉴定出的各种结构多样的酶抑制剂。